Paclitaxel Treatment and Proprotein Convertase 1/3 (PC1/3) Knockdown in Macrophages is a Promising Antiglioma Strategy as Revealed by Proteomics and Cytotoxicity Studies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Paclitaxel Treatment and Proprotein Convertase 1/3 (PC1/3) Knockdown in Macrophages is a Promising Antiglioma Strategy as Revealed by Proteomics and Cytotoxicity Studies

Published:2018-06 Issue:6 Volume:17 Page:1126-1143
ISSN:1535-9476
Container-title:Molecular & Cellular Proteomics
language:en
Short-container-title:Molecular & Cellular Proteomics

Author:

Duhamel Marie,Rose Mélanie,Rodet Franck,Murgoci Adriana Natalia,Zografidou Lea,Régnier-Vigouroux Anne,Abeele Fabien Vanden,Kobeissy Firas,Nataf Serge,Pays Laurent,Wisztorski Maxence,Cizkova Dasa,Fournier Isabelle,Salzet Michel

Funder

Région Nord Pas de Calais

SIRIC ONCOLille

Grant INCa-DGOS-Inserm

CCMIC APVV

Publisher

Elsevier BV

Subject

Molecular Biology,Biochemistry,Analytical Chemistry

Reference71 articles.

1. Hallmarks of Cancer: The Next Generation;Hanahan;Cell,2011

2. Cancer: Macrophages limit chemotherapy;De Palma;Nature,2011

3. The Role of tumor-associated macrophage in tumor progression;F.;Frontiers in Bioscience - Scholar,2012

4. A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide- doxorubicin-vincristine-prednisone;Taskinen;Clin. Cancer Res,2007

5. Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer;Shree;Genes Dev,2011

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Non-Metal Nanoparticle-Based Therapeutic Approaches for Glioblastoma Treatment;Biomedicines;2024-08-11

2. A co-culture system of macrophages with breast cancer tumoroids to study cell interactions and therapeutic responses;Cell Reports Methods;2024-06

3. Targeting tumor‑associated macrophages: Critical players in tumor progression and therapeutic strategies (Review);International Journal of Oncology;2024-04-30

4. Tumor-derived extracellular vesicles: how they mediate glioma immunosuppression;Molecular Biology Reports;2024-01-28

5. Development of Anti-Cancer Drugs for Tumor-Associated Macrophages: A Comprehensive Review and Mechanistic Insights;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3